HFE cross-talks with the MHC class I antigen presentation pathway

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• The HFE protein is primarily known for its role in iron metabolism.
• Its homology to major histocompatibility complex (MHC) class I molecules suggests potential immunologic functions, previously undescribed.
• Hereditary hemochromatosis (HH) is a genetic disorder linked to HFE gene mutations.

Purpose of the Study:

• To investigate the immunologic function of the HFE protein, specifically in relation to MHC class I molecules.
• To determine the impact of the C282Y HFE mutation, common in HH patients, on immune cell surface protein expression and function.

Main Methods:

• Analysis of peripheral blood mononuclear cells (PBMCs) from HH patients with the C282Y HFE mutation.
• Flow cytometry to assess cell-surface expression of MHC class I molecules.
• Biochemical assays and thermolability studies to investigate MHC class I molecule stability and peptide loading.

Main Results:

• PBMCs from C282Y HFE mutant patients exhibit reduced cell-surface MHC class I expression.
• This reduction is caused by accelerated endocytosis of MHC class I molecules, stemming from premature dissociation of peptide and beta2-microglobulin.
• Mutant cells show increased cell-surface free class I heavy chains and altered endoplasmic reticulum maturation of MHC class I.

Conclusions:

• The C282Y HFE mutation disrupts the classical MHC class I pathway, indicating a cross-talk between HFE and MHC class I trafficking.
• These findings reveal the first description of peptide presentation pathway abnormalities linked to HFE mutations.
• The study provides evidence for immunologic defects in patients with hereditary hemochromatosis, extending beyond iron metabolism.